Breast Lift in Fukushima JP
Breast Lift in Fukushima section, includes general infrmation about Breast Lift Procedure, Breast Lift Fukushima Local News, Breast Lift Fukushima Surgeon Locator and other Breast Lift related material.
Breast Lift Procedure
A mastopexy or breast lift is a surgical procedure performed to reshape the breast and return it to a more youthful position. Drooping of the breast may occur after pregnancy as well as aging. Frequently a breast implant may be used in conjunction with a breast lift in order to achieve better results. Depending on the amount of breast lifting that needs to be accomplished, different techniques may be used that involve different incisions. Generally, the more lifting that is required, the larger the incision (and therefore the scar).
Other Breast Lift Procedures
All Breast Procedures
Breast Lift fukushima (current)
fukushima Breast Reduction
fukushima Breast Implants
fukushima Implant Removal
fukushima Armpit Incision
More Fukushima info...
Fukushima By plane
It is a 40-minute bus ride from Fukushima Airport to Koriyama station (¥800), from which you will then have to travel to Fukushima station by Shinkansen (¥2920, 15 minutes) or local train (¥820, 45 minutes). It may be a bit more convenient to arrive in Tokyo and take the Shinkansen from there.
-
Fukushima By bus
Six daily buses called Abukuma depart from Shinjuku in Tokyo, at a cost of ¥4800 one way; the trip takes about five hours.
Kintetsu Bus' Galaxy overnight bus service runs from Osaka and Kyoto to Fukushima. It takes approximately 12 hours from Osaka (¥12740 one way) and 10 1/2 hours from Kyoto (¥12130 one way).
-
Plastic Surgery News...
- Patients with pancreatic cancer who receive external beam radiotherapy survive longer than those who are treated with surgery alone, according to the results of a retrospective analysis published in the Journal of Clinical Oncology.
- Analysis of epidemiological data indicates that regular use of NSAIDs modestly reduces risk of breast cancer; the clinical application of this, however, is uncertain.
There is much epidemiological evidence that NSAIDs are associated with decreased risk for several cancers, and there are known to be abnormalities in cyclo-oxygenase (COX) and in prostaglandin synthesis in breast cancer amongst others. The authors of this review aimed to review and assess the epidemiological evidence on the effect of these drugs on breast cancer risk.
They reviewed a range of existing meta-analyses, cohort, and case-control studies. Most studies indicated a protective effect, although the evidence is inconsistent: some studies have limited the effect to aspirin, and one large study showed an increase in risk associated with use of high-does NSAIDs but a reduction with low-dose aspirin. There is some evidence that NSAID use is associated with reduced progression of diagnosed breast cancer, and may delay or prevent metastatic disease.
Overall, they conclude that regular use of NSAID may reduce breast cancer risk by around 20%, although some evidence links this only to use of aspirin. Much more information is needed before these drugs could be advocated for prophylaxis, however. It is possible that there may be greater promise in established cancer as an adjunct to endocrine therapy, and a trial of celecoxib in this situation is currently in progress.